Bring efficiency and quality into medical writing and beyond through automation, globally and intelligently
Generative AI-Powered, comprehensive, unified, and composable clinical research platform
Powered by Generative AI, our unified Clinical Research Platform drives smarter trials, better data, and quicker results.
Learn morePowered by Generative AI
CSR First Draft
time reduction
Entire CSR Writing
time reduction
Protocol First Draft
time reduction
Safety Narratives
time reduction
Global tech leaders, AI-driven solutions, multilingual, and geopolitically agile
Led by senior executives from life sciences and computer sciences firms, offering unmatched expertise.
Integrated clinical research platform with streamlined data-document synergy for smart trials.
Backed by Microsoft Pegasus Program, Google for Startups; priority access to generative AI tech.
Offering turnkey AI products for immediate deployment and tailored projects for swift proof of concept.
Delivering secure, tailored global tech services, e.g. meeting US, and China’s stringent requirements.
Offering UI languages and LLM-based translations in English, Chinese, Japanese for faster submissions.
AuroraPrime Create shorten our authoring time by 40-50% with efficiency and quality." by Chief Medical Officer, big biopharma
"With AuroraPrime’s automation for Patient Safety Reports, we can reduce the time to generate batch draft reports from days or weeks to just seconds.” by Medical writing head, top global MNC
Offer secure and tailored tech services worldwide
AlphaLife Sciences has joined the NVIDIA Inception Program, enhancing our GenAI-powered platform, AuroraPrime. This strengthens our ability to deliver GenAI-copiloted medical writing solutions, improving efficiency and automating the clinical research process—from protocol design to CSR drafting—for pharmaceutical companies.
Aug 22, 2024
Our SVP Alice Hsu presented on AI-powered clinical trials at DIA 2024, showcasing AuroraPrime's transformative features. CEO Sharon Chen shared strategic insights as a panel expert, highlighting our innovative approaches.
Jul 18, 2024
At the SCDM China Conference 2024, Patrick Nadoiny, SCDM Chair and Global Head of Clinical Data Management at Sanofi, delivered an insightful presentation. Sharon Chen, our CEO, showcased innovative Gen-AI applications.
Jun 27, 2024
At the DIA Global Annual Meeting, AlphaLife Sciences showcased advanced generative AI solutions, revolutionizing clinical trials with unmatched efficiency and speed, transforming drug development.
Jun 21, 2024
AlphaLife Sciences joins Johnson & Johnson Innovation ‒ JLABS in Singapore, highlighting its promise in leveraging AI to accelerate clinical development and advance the medical AI field.
May 25, 2024
